Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
J Paul MonkMiguel A Villalona-Calero

Abstract

Maintaining dose-intensity with chemotherapeutic agents is hindered by a number of adverse effects including asthenia/fatigue. Tumor necrosis factor (TNF) is one of the cytokines responsible for the fatigue and cachexia associated with malignancies. We used etanercept (TNF-decoy receptor) to maintain dose-intensity of weekly docetaxel. Initially, 12 patients with advanced malignancies were randomly assigned to either docetaxel 43 mg/m2 weekly alone (cohort A) or the same docetaxel dose plus etanercept 25 mg subcutaneously twice weekly (cohort B). Subsequently, higher doses of docetaxel in combination with etanercept were evaluated. Pharmacokinetics (PKs), nuclear factor-kappa B (NF-kappaB) activation, and intracellular cytokines levels were measured. Patients completed weekly questionnaires quantifying asthenia/fatigue. Twenty-nine of 36 intended docetaxel doses during the first cycle were delivered in cohort A, and 35 of 36 doses were delivered in cohort B (P = .055). Three cohort B patients received additional cycles in the absence of disease progression or severe toxicity, whereas no patients from cohort A received additional cycles. Escalation to docetaxel 52 mg/m2 weekly with etanercept resulted in neutropenia, not fatigue...Continue Reading

References

Dec 9, 1976·Nature·L NortonA E Bogden
Nov 1, 1992·Medicinal Research Reviews·J M ArgilésF J López-Soriano
Jun 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L W KwakS J Horning
May 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H BurrisG Rodriguez
Aug 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D M SavareseF M Stewart
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J D HainsworthF A Greco
Oct 31, 1998·Current Opinion in Immunology·F J LejeuneD Liénard
May 6, 1999·The New England Journal of Medicine·D H PresentS J van Deventer
Aug 13, 1999·The American Journal of Physiology·D D LazarusP J Elliott
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H J BursteinE P Winer
Aug 8, 2001·Surgery·C B WeldonB S Beckman
Aug 16, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·James C. CusackAlbert S. Baldwin
Aug 16, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Mohamed Bentires-AljVincent Bours
Aug 22, 2001·Trends in Cell Biology·V Baud, M Karin
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gianni BonadonnaPinuccia Valagussa
Aug 27, 2004·Nature·Eli PikarskyYinon Ben-Neriah
May 5, 2005·International Journal of Oncology·P CostelliF Rossi Fanelli
Sep 22, 2005·Nature Reviews. Immunology·Michael Karin, Florian R Greten

❮ Previous
Next ❯

Citations

Oct 22, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Abbas H PanjuShabbir M H Alibhai
Sep 9, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kristine A Donovan, Paul B Jacobsen
Jul 16, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A GiacaloneU Tirelli
Jul 4, 2012·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·J M ArgilésS Busquets
Sep 16, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ebrahim HaroonAndrew H Miller
Oct 11, 2008·Nature Reviews. Cancer·Bostjan SerugaIan F Tannock
May 30, 2012·Nature Reviews. Clinical Oncology·Robert DantzerCharles S Cleeland
Aug 6, 2011·Nature Reviews. Immunology·Michael R Irwin, Steven W Cole
Aug 13, 2008·Journal of the National Cancer Institute·Ollie MintonPatrick Stone
Apr 24, 2009·Current Opinion in Pulmonary Medicine·Georgios T Stathopoulos, Ioannis Kalomenidis
Sep 16, 2011·Seminars in Dialysis·Maurizio BossolaLuigi Tazza
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julienne E BowerNajib Aziz
Feb 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew H MillerMichael R Irwin
Feb 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julienne E Bower
Aug 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julienne E BowerSteve W Cole
Nov 10, 2006·Annals of Surgical Oncology·Maurizio BossolaGiovan Battista Doglietto
Aug 13, 2014·Nature Reviews. Clinical Oncology·Julienne E Bower
Apr 11, 2014·International Review of Psychiatry·Jorge Luis SoteloCharles Nemeroff
Nov 6, 2007·Expert Opinion on Emerging Drugs·Josep M ArgilésSílvia Busquets
Oct 10, 2007·Expert Opinion on Investigational Drugs·Martin Braddock
Oct 29, 2009·Expert Opinion on Emerging Drugs·Kate T Murphy, Gordon S Lynch
Sep 23, 2010·Scandinavian Journal of Rheumatology·J C F van LuijnH G M Leufkens
Apr 22, 2014·Immunology and Allergy Clinics of North America·Daniela S MouraOlivier Hermine
Oct 21, 2016·Molecular Psychiatry·S Georgin-LavialleR Gaillard
Feb 24, 2016·Oncogenesis·P E Porporato
Aug 13, 2011·European Journal of Pharmacology·Josep M ArgilésFrancisco J López-Soriano
Sep 6, 2011·The Psychiatric Clinics of North America·Michael R Irwin
Jun 19, 2009·Journal of the American Academy of Dermatology·Bruce StroberMelodie Young
Nov 13, 2008·Pharmacology & Therapeutics·J KamathA Winokur
May 9, 2008·Cancer Letters·Preetha AnandBharat B Aggarwal
Sep 5, 2008·Sleep Medicine Clinics·Wayne A Bardwell, Sonia Ancoli-Israel
Dec 7, 2007·Psychoneuroendocrinology·Robert DantzerRaz Yirmiya
Dec 29, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A JagerC C D van der Rijt
Jun 5, 2007·Brain, Behavior, and Immunity·Julienne E Bower
Mar 18, 2016·CNS Oncology·Arash AsherJennifer K Hughes
Sep 20, 2015·Seminars in Cell & Developmental Biology·Erin E Talbert, Denis C Guttridge
Apr 1, 2015·British Journal of Haematology·Quentin A Hill, Adrian C Newland
Mar 19, 2014·Head & Neck·Marion E CouchHirak Der-Torossian
May 4, 2013·Brain, Behavior, and Immunity·Charles L Raison, Andrew H Miller
May 29, 2012·Brain, Behavior, and Immunity·Michael R IrwinReina Haque

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

© 2022 Meta ULC. All rights reserved